-
サマリー
あらすじ・解説
A 34-year-old female patient presents for treatment. She has been on and off medication for schizophrenia for years but has historically been non-adherent to pharmacotherapy because of the adverse effects. When considering olanzapine therapy for this patient, the PMHNP advises that she will need to be monitored for:
A. Absolute neutrophil count (ANC)
B. Hypertension, hyponatremia and hypertriglyceridemia
C. Extrapyramidal symptoms and irregular menses
D. Weight gain, hyperglycemia and dyslipidemia